Cambridge Investment Research Advisors
SGEN

Cambridge Investment Research Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,237
Closed -$475K – 3333
2023
Q3 		$475K Sell
2,237
-679
-23% -$136K ﹤0.01% 2127
2023
Q2 		$561K Buy
2,916
+813
+39% +$162K ﹤0.01% 2038
2023
Q1 		$426K Sell
2,103
-72
-3% -$11.5K ﹤0.01% 2205
2022
Q4 		$280K Sell
2,175
-1,075
-33% -$139K ﹤0.01% 2487
2022
Q3 		$445K Buy
3,250
+297
+10% +$48.4K ﹤0.01% 2036
2022
Q2 		$523K Buy
2,953
+91
+3% +$13.1K ﹤0.01% 1926
2022
Q1 		$412K Buy
2,862
+16
+0.6% +$2.17K ﹤0.01% 2268
2021
Q4 		$440K Sell
2,846
-553
-16% -$92.6K ﹤0.01% 2211
2021
Q3 		$577K Sell
3,399
-1,331
-28% -$207K ﹤0.01% 1939
2021
Q2 		$747K Sell
4,730
-9,748
-67% -$1.45M ﹤0.01% 1755
2021
Q1 		$2.01M Sell
14,478
-165
-1% -$26.6K 0.01% 1006
2020
Q4 		$2.56M Buy
14,643
+6,610
+82% +$1.23M 0.02% 800
2020
Q3 		$1.57M Buy
8,033
+3,994
+99% +$669K 0.01% 928
2020
Q2 		$686K Buy
+4,039
New +$603K 0.01% 1356

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Cambridge Investment Research Advisors's SGEN Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,237 shares — an estimated $475K sold.

Cambridge Investment Research Advisors first reported a position in SGEN in Q2 2020 and held it in 14 quarters. The position peaked at $2.56M in Q4 2020. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Cambridge Investment Research Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 2,237 Seagen Inc. Common Stock shares in Q4 2023, an estimated $475K.
  • Cambridge Investment Research Advisors first reported a position in Seagen Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's Seagen Inc. Common Stock position peaked at $2.56M in Q4 2020.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.